ArticleSerum interleukins 2 and 10 in juvenile systemic lupus erythematosus: relation to disease activity
ArticleSerum interleukins 2 and 10 in juvenile systemic lupus erythematosus: relation to disease activity
ArticleSerum level of Interleukin-33 and relation to disease activity in Juvenile Idiopathic Arthritis
ArticleSerum level of Interleukin-33 and relation to disease activity in Juvenile Idiopathic Arthritis
ArticleSerum Level Of Interleukin-23 in patients with Juvenile Idiopathic Arthritis and correlation to Disease Activity
ArticleSerum Level Of Interleukin-23 in patients with Juvenile Idiopathic Arthritis and correlation to Disease Activity
ArticleSerum nitric oxide and malondialdehyde as potential activity and severity markers of oxidative stress in juvenile idiopathic arthritis
ArticleSerum nitric oxide and malondialdehyde as potential activity and severity markers of oxidative stress in juvenile idiopathic arthritis
ArticleOutcomes of Tocilizumab on the Disease Activity in Children with Juvenile Idiopathic Arthritis
ArticleOutcomes of Tocilizumab on the Disease Activity in Children with Juvenile Idiopathic Arthritis
ArticleMONOCYTE CHEMOATTRACTANT PROTEIN-1, INTERLEUKIN-6 AND TUMOR NECROSIS FACTOR-a IN CHILDREN WITH JUVENILE RHEUMATOID ARTHRITIS
ArticleMONOCYTE CHEMOATTRACTANT PROTEIN-1, INTERLEUKIN-6 AND TUMOR NECROSIS FACTOR-a IN CHILDREN WITH JUVENILE RHEUMATOID ARTHRITIS